๐ŸŒ EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

๐Ÿงช

Trial Match

Clinical trials test new treatments โ€” sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

๐ŸŽฏ Match trials to me

30 recruiting trials

for Relapsed Sarcomas

FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma NCT04625907Phase 1, Phase 2128 sites๐Ÿ“ Brisbane๐Ÿ“ Camperdown๐Ÿ“ Clayton University of Birmingham ยท Tests: Irinotecan, Actinomycin D, Doxorubicin, Ifosfamide, Vincristine Study in Children and Adolescents of 177Lu-DOTATATE (Lutatheraยฎ) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed). NCT06607692Phase 1, Phase 21 site๐Ÿ“ Boadilla del Monte Fundaciรณn de investigaciรณn HM ยท Tests: Olaparib; 177Lu-DOTATATE This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma NCT07121946Phase 16 sites๐Ÿ“ Duarte๐Ÿ“ St Louis๐Ÿ“ Buffalo LTZ Therapeutics, Inc. ยท Tests: LTZ-301, LTZ-301, LTZ-301 Domatinostat With Sirolimus for Relapsed, Refractory Sarcoma and Osteosarcoma NCT07725380Phase 1, Phase 24 sites๐Ÿ“ Tampa๐Ÿ“ St Louis๐Ÿ“ The Bronx H. Lee Moffitt Cancer Center and Research Institute ยท Tests: Domatinostat, Sirolimus Daratumumab for Relapsed/Refractory Primary Effusion Lymphoma, Plasmablastic Lymphoma, and Multicentric Castleman Disease NCT05907759Phase 21 site๐Ÿ“ Bethesda National Cancer Institute (NCI) ยท Tests: Daratumumab SC SynKIR-310 for Relapsed/Refractory B-NHL NCT06544265Phase 15 sites๐Ÿ“ Denver๐Ÿ“ Atlanta๐Ÿ“ Fairway Verismo Therapeutics ยท Tests: SynKIR-310 An Observational Study of Local Relapse After High Grade Osteosarcoma NCT06017518n/a2 sites๐Ÿ“ Bologna๐Ÿ“ Pisa Istituto Ortopedico Rizzoli A Study of PHST001 in Advanced Solid Tumors NCT06840886Phase 120 sites๐Ÿ“ Beverly Hills๐Ÿ“ Los Angeles๐Ÿ“ Palo Alto Pheast Therapeutics ยท Tests: PHST001, Paclitaxel, Topotecan, Doxorubicin, FOLFIRI NKG2D.Zeta-NK Cell Conditioning With C7R.GD2.CAR-T Cells for Patients With Relapsed or Refractory Osteosarcoma or Neuroblastoma NCT07211737Phase 11 site๐Ÿ“ Houston Baylor College of Medicine ยท Tests: i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells, i15.NKG2D.zeta NK cells and C7R.GD2.CARTs cells, i15.NKG2D.zeta NK celโ€ฆ Study to Evaluate the Effectiveness of Tafasitamab in Combination With Lenalidomide Followed by Tafasitamab Monotherapy in Relapsed or Refractory Diffuse Large B-cell Lymphoma Non-transplant Eligible Patients in Italy (PRO-MIND) NCT06299553n/a1 site๐Ÿ“ Milan Incyte Biosciences Italy S.r.l Genomic Profiles Analysis in Children, Adolescents and Young Adult With Sarcomas NCT04621201n/a10 sites๐Ÿ“ Torino๐Ÿ“ Bologna๐Ÿ“ Bologna Azienda Ospedaliera Ospedale Infantile Regina Margherita Saโ€ฆ ยท Tests: observation and biopsy GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours NCT07297667Phase 14 sites๐Ÿ“ Calgary๐Ÿ“ Ottawa๐Ÿ“ Toronto Canadian Cancer Trials Group ยท Tests: Fludarabine, Cyclophosphamide, GCAR1 A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML NCT05735184Phase 144 sites๐Ÿ“ Phoenix๐Ÿ“ La Jolla๐Ÿ“ Los Angeles Kura Oncology, Inc. ยท Tests: Ziftomenib, Venetoclax, Azacitidine, Daunorubicin, Cytarabine Evaluate the Safety and Clinical Activity of HH2853 NCT04390737Phase 1, Phase 225 sites๐Ÿ“ Phoenix๐Ÿ“ Jacksonville๐Ÿ“ Rochester Haihe Biopharma Co., Ltd. ยท Tests: HH2853 Tablets Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas NCT05210374Phase 11 site๐Ÿ“ Cleveland Case Comprehensive Cancer Center ยท Tests: Disulfiram, Copper Gluconate, Liposomal Doxorubicin (Doxil) Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma NCT03721068Phase 12 sites๐Ÿ“ Atlanta๐Ÿ“ Chapel Hill UNC Lineberger Comprehensive Cancer Center ยท Tests: iC9.GD2.CAR.IL-15 T-cells, Cyclophosphamide, Fludarabine Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas NCT06156410Phase 14 sites๐Ÿ“ San Francisco๐Ÿ“ Aurora๐Ÿ“ Philadelphia Children's Hospital of Philadelphia ยท Tests: Cabozantinib Evaluation of Xaluritamig in Adults, Adolescents and Children With Relapsed or Refractory Ewing Sarcoma (EWS) NCT07297979Phase 111 sites๐Ÿ“ Los Angeles๐Ÿ“ Los Angeles๐Ÿ“ Baltimore Amgen ยท Tests: Xaluritamig Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors NCT07584499Phase 11 site๐Ÿ“ Guangzhou Sun Yat-sen University ยท Tests: Becotatug Vedotin A Study of Circulating Tumor DNA (ctDNA) Testing for People With B-Cell Lymphoma NCT06736613Phase 27 sites๐Ÿ“ Basking Ridge๐Ÿ“ Middletown๐Ÿ“ Montvale Memorial Sloan Kettering Cancer Center ยท Tests: Cerebral Spinal Fluid ctDNA Safety, Pharmacokinetics, and Clinical Activity of LP-284 in Adult Patients With Relapsed or Refractory Lymphomas and Solid Tumors NCT06132503Phase 11 site๐Ÿ“ West Valley City Lantern Pharma Inc. ยท Tests: LP-284 Efficacy and Safety of Regorafenib as Maintenance Therapy After First-line Treatment in Patients With Bone Sarcomas NCT04055220NA16 sites๐Ÿ“ Besanรงon๐Ÿ“ Bordeaux๐Ÿ“ Lille Centre Leon Berard ยท Tests: Treatment by Regorafenib, Surveillance Epcoritamab (Epcor)-Containing Combination Salvage Therapy Followed by ASCT & Epcor Consolidation in Patients With Relapsed LBCL NCT06287398Phase 21 site๐Ÿ“ Melbourne Australasian Leukaemia and Lymphoma Group ยท Tests: Epcoritamab DFMO Maintenance for Patients With Relapsed/Refractory Ewing Sarcoma or Osteosarcoma NCT06892678Phase 1, Phase 21 site๐Ÿ“ The Bronx Montefiore Medical Center ยท Tests: DFMO TLN-499 in Combination With Venetoclax in Patients With Relapsed/Refractory Solid Tumors NCT07713732Phase 13 sites๐Ÿ“ Camperdown๐Ÿ“ Malvern๐Ÿ“ Nedlands Treeline Biosciences, Inc. ยท Tests: TLN-499, Venetoclax Clinical Study of C402-CD19-CAR Treatment in Subjects With Relapsed or Refractory B-cell Lymphoma NCT06830031Phase 11 site๐Ÿ“ Tianjin Shanghai Exuma Biotechnology Ltd. ยท Tests: C402-CD19-CAR A Multi-Institution Study of TGFฮฒ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue NCT05634369Phase 1, Phase 222 sites๐Ÿ“ South Birmingham๐Ÿ“ Phoenix๐Ÿ“ Little Rock Nationwide Children's Hospital ยท Tests: GEM/DOX + TGFBi expanded NK cells Losartan + Sunitinib in Treatment of Osteosarcoma NCT03900793Phase 14 sites๐Ÿ“ Los Angeles๐Ÿ“ Aurora๐Ÿ“ Aurora University of Colorado, Denver ยท Tests: Losartan, Sunitinib Reduced Intensity Haploidentical BMT for High Risk Solid Tumors NCT01804634Phase 23 sites๐Ÿ“ Baltimore๐Ÿ“ The Bronx๐Ÿ“ Valhalla Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins ยท Tests: Cyclophosphamide, Fludarabine, low dose total body irradiation, Melphalan, Tacrolimus Actinium Therapy for Late-stage Aggressive Sarcomas NCT07156565Phase 16 sites๐Ÿ“ Los Angeles๐Ÿ“ Rochester๐Ÿ“ New York Ratio Therapeutics, Inc. ยท Tests: [Ac 225]RTX-2358, [Cu64]LNTH-1363S
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy